AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.
AmacaThera has raised $50K in total funding. The most recent round was Grant. The last funding was announced in December 2023.
AmacaThera's investors include Lumira Ventures, Creative Destruction Lab, Inveready, StandUp Ventures, MBX Capital.
AmacaThera is headquartered in Toronto, Canada.
AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.
AmacaThera is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AmacaThera — Funding & Investors." VCBacked, December 1, 2023, https://www.vcbacked.co/company/amacathera. Accessed September 29, 2026.
VCBacked. (2023). AmacaThera — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/amacathera
{{cite web |title=AmacaThera — Funding & Investors |url=https://www.vcbacked.co/company/amacathera |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated